Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546298 · ClinicalTrials.gov registry record
Immune Reactions in Contact Dermatitis Affected Skin
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 9
- Enrollment target
NCT01546298: Completed study, sponsored by Rockefeller University.
NCT01546298 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01546298 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study hopes to improve the investigators understanding of how the immune system acts in allergic contact dermatitis. In order to reach this goal, normal volunteers, who are suspected of having allergic contact dermatitis, will be patch tested for the fifteen most common allergens. Then, biopsies will be taken of the skin at the sites where the there is a positive reaction to the allergen. Also, small biopsies will be taken from an area that received a patch but no allergen and an area that did not receive a patch to serve as controls. In a second stage of the study, volunteers will receive patches with the allergen to which they demonstrated an allergic response. More biopsies will be taken, over three designated time points. The biopsied skin samples will then be studied in a laboratory.
Primary Outcome
The response elicited by the allergen on relevant immune pathways as measured by cytokine levels in skin of IFNγ (Th1 pathway), IL-13 (Th2 pathway), IL-9 (Th9 pathway), IL-17 (Th17 pathway) and IL-22 (Th22 pathway).
Interventions
- OTHER Patch tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-12-14 |
What the finished NCT01546298 record still lists
NCT01546298 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patch tests is the first listed.
NCT01546298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01546298 about?
NCT01546298 is a clinical study titled "Immune Reactions in Contact Dermatitis Affected Skin". This study hopes to improve the investigators understanding of how the immune system acts in allergic contact dermatitis. In order to reach this goal, normal volunteers, who are suspected of having allergic contact dermatitis, will be patch tested for the fifteen most common allergens. Then, biopsie...
What is the current status of trial NCT01546298?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2012-12-14.
What interventions are being tested in trial NCT01546298?
The interventions under investigation include: Patch tests (OTHER).
Who is sponsoring clinical trial NCT01546298?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia